Efficacy of "Attachment-Based Compassion Therapy" in the Treatment of Fibromyalgia: A Randomized Controlled Trial

Jesús Montero-Marín, Mayte Navarro-Gil, Marta Puebla-Guedea, Juan V Luciano, William Van Gordon, Edo Shonin, Javier García-Campayo, Jesús Montero-Marín, Mayte Navarro-Gil, Marta Puebla-Guedea, Juan V Luciano, William Van Gordon, Edo Shonin, Javier García-Campayo

Abstract

Objective: There is a growing interest in evaluating the effectiveness of compassion interventions for treating psychological disorders. The present study evaluated the effectiveness of "attachment-based compassion therapy" (ABCT) in the treatment of fibromyalgia (FM), and the role of psychological flexibility as a mediator of improvements.

Methods: A total of 42 patients with FM were randomly assigned to ABCT or relaxation (active control group). Both the intervention and control condition were combined with treatment as usual (TAU). The primary outcome was functional status (FIQ), and the secondary outcomes were clinical severity (CGI-S), pain catastrophizing (PCS), anxiety (HADS-A), depression (HADS-D), quality of life (EQ-5D), and psychological flexibility (AAQ-II). Differences between the groups were estimated using mixed-effects models, and mediation assessments were conducted using path analyses.

Results: The ABCT group demonstrated superior outcomes compared to the relaxation group, including better FIQ values after treatment (B = -3.01; p = 0.003). Differences in FIQ were maintained at 3-month follow-up (B = -3.33; p = 0.001). The absolute risk reduction in ABCT compared to relaxation increased by 40.0%, with an NNT = 3 based on criteria of ≥50% FIQ reduction after treatment. Psychological flexibility had a significant mediating effect on improvements.

Conclusion: These results suggest that ABCT combined with TAU appears to be effective in the treatment of FM symptoms.

Clinical trial registration: http://ClinicalTrials.gov, identifier NCT02454244.

Keywords: attachment-based compassion therapy; compassion; fibromyalgia; psychological flexibility; randomized controlled trial.

Figures

Figure 1
Figure 1
Flowchart of participants in the randomized controlled trial.

References

    1. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology Preliminary Diagnostic Criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (2010) 62(5):600–10.10.1002/acr.20140
    1. Vincent A, Whipple MO, McAllister SJ, Aleman KM, St Sauver JL. A cross-sectional assessment of the prevalence of multiple chronic conditions and medication use in a sample of community-dwelling adults with fibromyalgia in Olmsted County, Minnesota. BMJ Open (2015) 5(3):e006681.10.1136/bmjopen-2014-006681
    1. Branco JC, Bannwarth B, Failde I, Abello Carbonell J, Blotman F, Spaeth M, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum (2010) 39(6):448–53.10.1016/j.semarthrit.2008.12.003
    1. Chandran A, Schaefer C, Ryan K, Baik R, McNett M, Zlateva G. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. J Manag Care Pharm (2012) 18(6):415–26.10.18553/jmcp.2012.18.6.415
    1. Häuser W, Wolfe F, Tölle T, Üçeyler N, Sommer C. The role of antidepressants in the management of fibromyalgia syndrome. CNS Drugs (2012) 26(4):297–307.10.2165/11598970-000000000-00000
    1. Hassett AL, Gevirtz RN. Nonpharmacologic treatment for fibromyalgia: patient education, cognitive-behavioral therapy, relaxation techniques, and complementary and alternative medicine. Rheum Dis Clin North Am (2009) 35(2):393–407.10.1016/j.rdc.2009.05.003
    1. Nüesch E, Häuser W, Bernardy K, Barth J, Jüni P. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis (2013) 72(6):955–62.10.1136/annrheumdis-2011-201249
    1. Thieme K, Flor H, Turk DC. Psychological pain treatment in fibromyalgia syndrome: efficacy of operant behavioural and cognitive behavioural treatments. Arthritis Res Ther (2006) 8(4):R121.10.1186/ar1863
    1. Bernardy K, Fuber N, Kollner V, Häuser W. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome – a systematic review and metaanalysis of randomized controlled trials. J Rheumatol (2010) 37(10):1991–2005.10.3899/jrheum.100104
    1. Luciano JV, Guallar JA, Aguado J, López-del-Hoyo Y, Olivan B, Magallón R, et al. Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study). Pain (2014) 155(4):693–702.10.1016/j.pain.2013.12.029
    1. Luciano JV, D’Amico F, Feliu-Soler A, McCracken LM, Aguado J, Peñarrubia-María MT, et al. Cost-utility of group acceptance and commitment therapy for fibromyalgia versus recommended drugs: an economic analysis alongside a 6-month randomized controlled trial conducted in Spain (EFFIGACT Study). J Pain (2017) 18(7):868–80.10.1016/j.jpain.2017.03.001
    1. Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther (2006) 44(1):1–25.10.1016/j.brat.2005.06.006
    1. Lindsay EK, Creswell JD. Mechanisms of mindfulness training: monitor and acceptance theory (MAT). Clin Psychol Rev (2017) 51:48–59.10.1016/j.cpr.2016.10.011
    1. Cash E, Salmon P, Weissbecker I, Rebholz WN, Bayley-Veloso R, Zimmaro LA, et al. Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial. Ann Behav Med (2015) 49(3):319–30.10.1007/s12160-014-9665-0
    1. Lauche R, Cramer H, Dobos G, Langhorst J, Schmidt S. A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. J Psychosom Res (2013) 75(6):500–10.10.1016/j.jpsychores.2013.10.010
    1. Van Gordon W, Shonin E, Dunn TJ, Garcia-Campayo J, Griffiths MD. Meditation awareness training for the treatment of fibromyalgia syndrome: a randomized controlled trial. Br J Health Psychol (2017) 22(1):186–206.10.1111/bjhp.12224
    1. Langhorst J, Häuser W, Bernardy K, Lucius H, Settan M, Winkelmann A, et al. Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline. Schmerz (2012) 26(3):311–7.10.1007/s00482-012-1178-9
    1. Strauss C, Lever Taylor B, Gu J, Kuyken W, Baer R, Jones F, et al. What is compassion and how can we measure it? A review of definitions and measures. Clin Psychol Rev (2016) 47:15–27.10.1016/j.cpr.2016.05.004
    1. Fredrickson BL, Cohn MA, Coffey KA, Pek J, Finkel SM. Open hearts build lives: positive emotions, induced through loving-kindness meditation, build consequential personal resources. J Pers Soc Psychol (2008) 95(5):1045–62.10.1037/a0013262
    1. Pace TW, Negi LT, Adame DD, Cole SP, Sivilli TI, Brown TD, et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology (2009) 34(1):87–98.10.1016/j.psyneuen.2008.08.011
    1. Leaviss J, Uttley L. Psychotherapeutic benefits of compassion-focused therapy: an early systematic review. Psychol Med (2015) 45(5):927–45.10.1017/s0033291714002141
    1. García-Campayo J, Navarro-Gil M, Demarzo M. Attachment-based compassion therapy. Mindfulness Compassion (2016) 1(2):68–74.10.1016/j.mincom.2016.10.004
    1. Fearon RMP, Roisman GI. Attachment theory: progress and future directions. Curr Opin Psychol (2017) 15:131–6.10.1016/j.copsyc.2017.03.002
    1. Meeus M, Nijs J, Vanderheiden T, Baert I, Descheemaeker F, Struyf F, et al. The effect of relaxation therapy on autonomic functioning, symptoms and daily functioning, in patients with chronic fatigue syndrome or fibromyalgia: a systematic review. Clin Rehabil (2015) 29(3):221–33.10.1177/0269215514542635
    1. García-Campayo J, Rodero B, del Hoyo YL, Luciano JV, Alda M, Gili M. Validation of a Spanish language version of the pain self-perception scale in patients with fibromyalgia. BMC Musculoskelet Disord (2010) 11(1):255.10.1186/1471-2474-11-255
    1. Rivera J, González T. The fibromyalgia impact questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol (2004) 22(5):554–60.
    1. Díaz-Marsá M, Palomares N, Morón MD, Tajima K, Fuentes ME, López-Ibor JJ, et al. Psychological factors affecting response to antidepressant drugs in fibromyalgia. Psychosomatics (2011) 52(3):237–44.10.1016/j.psym.2010.12.014
    1. Dindo L, Van Liew JR, Arch JJ. Acceptance and commitment therapy: a transdiagnostic behavioral intervention for mental health and medical conditions. Neurotherapeutics (2017) 14(3):546–53.10.1007/s13311-017-0521-3
    1. García Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S. [Validation of the Spanish version of the pain catastrophizing scale in fibromyalgia]. Med Clin (2008) 131(13):487–92.10.1157/13127277
    1. Vallejo MA, Rivera J, Esteve-Vives J, Rodríguez-Muñoz MF. Use of the Hospital Anxiety and Depression Scale (HADS) to evaluate anxiety and depression in fibromyalgia patients. Rev Psiquiatr Salud Ment (2012) 5(2):107–14.10.1016/j.rpsmen.2012.01.004
    1. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European quality of life scale. Med Clin (1999) 112:79–85.
    1. Ruiz FJ, Langer Herrera AI, Luciano C, Cangas AJ, Beltrán I. Measuring experiential avoidance and psychological inflexibility: the Spanish version of the acceptance and action questionnaire – II. Psicothema (2013) 25(1):123–9.10.7334/psicothema2011.239
    1. Egbewale BE, Lewis M, Sim J. Bias, precision and statistical power of analysis of covariance in the analysis of randomized trials with baseline imbalance: a simulation study. BMC Med Res Methodol (2014) 14(1):49.10.1186/1471-2288-14-49
    1. Morris SB. Estimating effect sizes from pretest-posttest-control group designs. Organ Res Methods (2008) 11(2):364–86.10.1177/1094428106291059
    1. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol (2005) 23(5 Suppl 39):S154–62.
    1. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain (2009) 146(3):238–44.10.1016/j.pain.2009.08.019
    1. Lockhart G, MacKinnon DP, Ohlrich V. Mediation analysis in psychosomatic medicine research. Psychosom Med (2011) 73(1):29–43.10.1097/PSY.0b013e318200a54b
    1. Meinlschmidt G, Tegethoff M. Psychotherapie: Quo vadis? Fortschr Neurol Psychiatr (2017) 85(8):479–94.10.1055/s-0043-113131
    1. Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. Psychological treatments for fibromyalgia: a meta-analysis. Pain (2010) 151(2):280–95.10.1016/j.pain.2010.06.011
    1. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med (1988) 318(26):1728–33.10.1056/NEJM198806303182605
    1. Dionne F, Ngô T-L, Blais M-C. The psychological flexibility model: a new approach to mental health. Santé Ment Qué (2013) 38(2):111–30.10.7202/1023992ar
    1. Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, et al. Preliminary psychometric properties of the acceptance and action questionnaire–II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther (2011) 42(4):676–88.10.1016/j.beth.2011.03.007
    1. Bakhshaie J, Kauffman BY, Viana AG, Garza M, Ochoa-Perez M, Lemaire C, et al. Synergistic effects of pain intensity and experiential avoidance in relation to anxiety symptoms and disorders among economically disadvantaged latinos in a community-based primary care setting. J Anxiety Disord (2016) 48:54–62.10.1016/j.janxdis.2016.08.004
    1. Ablin JN, Zohar AH, Zaraya-Blum R, Buskila D. Distinctive personality profiles of fibromyalgia and chronic fatigue syndrome patients. PeerJ (2016) 4:e2421.10.7717/peerj.2421
    1. Yim Y-R, Lee K-E, Park D-J, Kim SH, Nah SS, Lee JH, et al. Identifying fibromyalgia subgroups using cluster analysis: relationships with clinical variables. Eur J Pain (2016) 21(2):374–84.10.1002/ejp.935

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe